Definium Therapeutics updates DT120 clinical trials and commercial plans

Go back to Definium Therapeutics updates DT120 clinical trials and commercial plans
(NASDAQ: DFTX) Delayed: 44.33 +0.14 (0.32%)
Previous Close $44.19    52 Week High
Open $43.76    52 Week Low
Day High $44.75    P/E N/A 
Day Low $43.26    EPS
Volume 2,074,713